, India
Photo by Piret Ilver from Unsplash

Chubb plans 49% stake in Kotak General Insurance

Kotak General Insurance was deemed a favoured candidate compared to Zurich Insurance Group.

Insurer Chubb is currently in discussions to acquire a 49% stake in India's Kotak General Insurance, reported by Reuters.

The Indian insurer has become a more favoured candidate compared to Zurich Insurance Group, according to sources with direct knowledge of the talks.

READ MORE: Exclusive: Chubb seeks 49% of India's Kotak General Insurance, has edge over Zurich -sources

Chubb's appeal lies in its willingness to let Kotak Mahindra Bank retain control and its shared focus on common business areas, such as auto insurance. 

Zurich, on the other hand, has been discussing a stake of either 49% or 51%, valuing the company at approximately $800m for a majority stake.

If Chubb wins the deal, the valuation of Kotak would be less than $800m, as it wouldn't include a buyout premium. 

ALSO READ: Chubb Head of Property Asia role lands on Adrian Habils

Kotak General Insurance has been seeking a stake sale to accelerate growth in a market with significant potential.

Chubb's entry into the Indian market would mark a fresh attempt after a previous deal with HDFC General Insurance in 2007. 

 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.